Archived Newsletters

31. 05.28.25 -- Evolve Or Fade Away? Biotech's Outsourcing Moment In Trump's Tariff Tangle 5/28/2025
    05/28/25 Outsourced Pharma Newsletter
32. 05.27.25 -- Fill/Finish Services, Technologies, And Innovations 5/27/2025
    05/27/25 Outsourced Pharma Newsletter
33. 05.27.25 -- STREAM Edition: ADC Heterogeneity, Site-Specific Conjugation 5/27/2025

    05/27/25 Outsourced Pharma Newsletter

34. 05.27.25 -- Lilly's CEO Building On The Trump Agenda 5/27/2025
    05/27/25 Outsourced Pharma Newsletter
35. 05.23.25 -- Find Your CDMO For Biologic API & Drug Product Manufacturing 5/23/2025
    05/23/25 Outsourced Pharma Newsletter
36. 05.23.25 -- Direct Access To Today's Leading CDMOs 5/23/2025
    05/23/25 Outsourced Pharma Newsletter
37. 05.23.25 -- Squeezing CDMOs Dry? One Big Pharma VP Says Enough Is Enough 5/23/2025
    05/23/25 Outsourced Pharma Newsletter
38. 05.22.25 -- Questions About Your Small Molecule API And Drug Product Projects? 5/22/2025
    05/22/25 Outsourced Pharma Newsletter
39. 05.22.25 -- Your Next CDMO Partner Could Be Just A Click Away 5/22/2025
    05/22/25 Outsourced Pharma Newsletter
40. 05.22.25 -- Investors Create A U.S. Biotech With GLP-1 Assets From China 5/22/2025
    05/22/25 Outsourced Pharma Newsletter